Obstructive Sleep Apnea, Resting Heart Rate, and Glycemic Variability in Adults With Maturity-Onset Diabetes of the Young
Open accessPublished version of a preprint
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index; 9 of the 19 sources its claims cite were checked for support.
Abstract
Obstructive sleep apnea (OSA) is a common condition strongly linked to increased cardiovascular risk and poor glycemic control. Little is known about OSA, cardiovascular risk, and glycemia in maturity-onset diabetes of the young (MODY), an inherited form of diabetes, which is different than both type 1 and type 2 diabetes. We assessed OSA, resting heart rate (RHR), an important prognostic marker of cardiovascular disease, and glycemic variability among the most common subtypes of MODY, glucokinase (GCK)-MODY, and transcription factor (TF)-related MODY (HNF1A, HNF4A, and HNF1B). Adults with GCK-MODY (n = 63) and TF-related MODY (n = 60) and control adults without diabetes (n = 65) were screened for OSA by home sleep test. Glycemic variability (continuous glucose monitoring) and RHR (wearable sleep-activity tracker) were concomitantly assessed for 2 weeks at home. Data from 188 individuals (2,853 recorded days) were analyzed. Individuals with TF-related MODY, compared with those with GCK-MODY or control individuals, had more OSA (48.3%, 27.0%, and 30.8%, respectively; P = 0.033), higher RHR (72.8 ± 10.8, 65.2 ± 7.9, and 67.3 ± 7.7 bpm, respectively; P < 0.001), and higher glycemic variability (coefficient of variation of glucose 31.6 ± 6.0%, 17.3 ± 4.5%, and 17.5 ± 4.0%, respectively; P < 0.001). Greater severity of OSA and higher RHR were associated with higher glycemic variability. These findings may have important clinical implications for cardiovascular risk assessment in MODY. Article Highlights: Obstructive sleep apnea (OSA) has been strongly linked to increased cardiovascular risk and poor glycemic control in the general population. Resting heart rate (RHR) is a prognostic marker of cardiovascular morbidity and mortality and has been linked to dysglycemia. Little is known about OSA, RHR, and glycemia in maturity-onset diabetes of the young (MODY), an inherited form of diabetes with discrete clinical features. Adults with transcription factor–related MODY (HNF1A, HNF4A, and HNF1B) had more OSA and higher RHR and greater glycemic variability compared with those with glucokinase-MODY or control adults without diabetes, which may have important clinical implications for future cardiovascular risk.
Overview
CoChat Summary
TL;DR
In adults with maturity-onset diabetes of the young (MODY), transcription factor–related MODY (HNF1A, HNF4A, HNF1B) was associated with more obstructive sleep apnea (OSA), higher resting heart rate (RHR), and greater glycemic variability than GCK-MODY or control adults without diabetes. Greater OSA severity and higher RHR were associated with higher glycemic variability among MODY participants.
Key findings
- TF-related MODY vs GCK-MODY vs control participants had more OSA (48.3%, 27.0%, and 30.8%, respectively; P = 0.033), higher RHR (72.8 ± 10.8, 65.2 ± 7.9, and 67.3 ± 7.7 bpm; P < 0.001), and higher glucose coefficient of variation (31.6 ± 6.0%, 17.3 ± 4.5%, and 17.5 ± 4.0%; P < 0.001).
- TF-related MODY had less time in range (76.7 ± 17.8% vs 94.4 ± 5.8% in GCK-MODY and 93.3 ± 8.7% in control participants), more time above range, and more time below range.
- Among MODY participants, greater OSA severity (R² = 0.059, P = 0.007 using AHI) and higher RHR (R² = 0.017, P = 0.024) correlated with higher glucose variability; every 5-bpm increase in RHR was associated with a 3% increase in glucose variability.
- Overall, 37% of all MODY participants had OSA despite clinical characteristics not representing traditional OSA risk factors.
Methods
- Adults with GCK-MODY (n = 63), TF-related MODY (n = 60), and control adults without diabetes (n = 65) were recruited from the University of Chicago’s Monogenic Diabetes Registry from June 2022 to July 2023; 188 individuals and 2,853 recorded days were analyzed.
- Participants completed home assessments including a 2-week wearable sleep-activity tracker (Fitbit Inspire 2) for sleep and RHR, continuous glucose monitoring (FreeStyle Libre Pro), and one night of home sleep apnea screening; OSA was defined as AHI ≥ 5.
- Statistical analysis used Stata version 18, with no imputation for missing values; no formal adjustment for multiple comparisons was made, and statistical significance was defined as P < 0.01.
Limitations
- The paper states racial and ethnic differences between MODY and control participants, with MODY participants predominantly non-Hispanic White and more Hispanic and Asian control participants; analyses adjusted for race, and sensitivity analysis among non-Hispanic White individuals showed similar conclusions.
- The paper states that EKG data were not collected, control participants were not tested for MODY, and insulin use was higher in TF-related MODY than GCK-MODY, though sensitivity analysis among those not on insulin yielded similar conclusions.
- The paper states the study was not designed to examine underlying mechanisms, and the modest associations warrant future investigations with larger sample sizes; the text also makes evident that the single-night home sleep apnea test and cross-sectional observational design limit assessment of night-to-night OSA variability and causality.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
7 Valid · 1 Not valid · 7 Not checked · 23 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Participants with TF-related MODY and GCK-MODY had similar average glucose values”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Participants with TF-related MODY showed higher rates of hyperlipidemia compared with those with GCK-MODY and control participants.”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“there was a greater proportion of those with TF-related MODY (56.7%) with an RHR ≥ 70 bpm.”
- Also stated in: § DISCUSSION · p. 6 · plain
“TF-related MODY, 43.3% with resting heart rate below 70 bpm and 56.7% at or above”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Also stated in: § DISCUSSION · p. 6 · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In our study, RHR was, on average, ∼ 5-7 bpm higher in participants with TF-related MODY compared with those with GCK-MODY or control participants”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Despite similar average glucose levels, participants with TF-related MODY had higher glycemic variability, more hypoglycemia, and less time in range compared with those with GCK-MODY or control participants.”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
11 more claims
Create a free account to see all 38 claims and every source verdict.
- Probably not a substantial claim. 21
- It may state two separate claims as one. 5
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ RESULTS · p. 4
“| Male | 14 (22.2) | 18 (30.0) | 20 (30.8) | - |”
§ RESULTS · p. 4
“| None (male) | 14 (22.2) | 18 (30.0) | 19 (29.2) | - |”
Citations
Cites
Sympathetic neural mechanisms in obstructive sleep apnea.
Somers, V. K., Dyken, M. E., Clary, M. P., & Abboud, F. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118235 · Cited by 2,527
Yeghiazarians, Y., Jneid, H., Tietjens, J. R., Redline, S., Brown, D. L., El-Sherif, N., Mehra, R., Bozkurt, B., Ndumele, C. E., Somers, V. K., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000988 · Cited by 1,431
Aune, D., Keum, N., Giovannucci, E., Fadnes, L. T., Boffetta, P., Greenwood, D. C., Tonstad, S., Vatten, L. J., Riboli, E., & Norat, T. (2016) · BMC Medicine · doi:10.1186/s12916-016-0730-3 · Cited by 401
Shields, B. M., McDonald, T. J., Ellard, S., Campbell, M. J., Hyde, C., & Hattersley, A. T. (2012) · Diabetologia · doi:10.1007/s00125-011-2418-8 · Cited by 335
Aune, D., Sen, A., ó'Hartaigh, B., Janszky, I., Romundstad, P. R., Tonstad, S., & Vatten, L. J. (2017) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.04.004 · Cited by 284
Obstructive sleep apnoea and type 2 diabetes mellitus: a bidirectional association
Aurora, R. N., & Punjabi, N. M. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70039-0 · Cited by 273
Aune, D., Norat, T., Romundstad, P., & Vatten, L. J. (2014) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.10.028 · Cited by 225
Sympathetic Neural Mechanisms in Obstructive Sleep Apnea
SOMERS, V (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(96)82092-9 · Cited by 195
Treatment options for MODY patients: a systematic review of literature
Delvecchio, M., Pastore, C., & Giordano, P. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00864-4 · Cited by 172
Obstructive Sleep Apnea in Young Lean Men
Pamidi, S., Wroblewski, K., Broussard, J., Day, A., Hanlon, E. C., Abraham, V., & Tasali, E. (2012) · Diabetes Care · doi:10.2337/dc12-0841 · Cited by 137
Self-citationSteele, A. M., Shields, B. M., Shepherd, M., Ellard, S., Hattersley, A. T., & Pearson, E. R. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02913.x · Cited by 130
Picard, M., Tauveron, I., Magdasy, S., Benichou, T., Bagheri, R., Ugbolue, U. C., Navel, V., & Dutheil, F. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251863 · Cited by 130
Hillis, G. S., Woodward, M., Rodgers, A., Chow, C. K., Li, Q., Zoungas, S., Patel, A., Webster, R., Batty, G. D., Ninomiya, T., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2471-y · Cited by 117
Riddle, M. C., Philipson, L. H., Rich, S. S., Carlsson, A., Franks, P. W., Greeley, S. A. W., Nolan, J. J., Pearson, E. R., Zeitler, P. S., & Hattersley, A. T. (2020) · Diabetes Care · doi:10.2337/dci20-0065 · Cited by 117
Self-citationHeart rate as a predictor of cardiovascular risk
Tadic, M., Cuspidi, C., & Grassi, G. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12892 · Cited by 97
Cardiac sympathovagal balance during sleep apnea episodes
Vanninen, E. J., Tuunainen, A., Kansanen, M., Uusitupa, M. I. J., & Länsimies, E. (1996) · Clinical Physiology · doi:10.1111/j.1475-097x.1996.tb00569.x · Cited by 96
The Effect of Intensive Diabetes Treatment on Resting Heart Rate in Type 1 Diabetes
Paterson, A. D., Rutledge, B. N., Cleary, P. A., Lachin, J. M., Crow, R. S., & for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2007) · Diabetes Care · doi:10.2337/dc06-1441 · Cited by 81
Aune, D., ó Hartaigh, B., & Vatten, L. J. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.02.008 · Cited by 73
Hillis, G. S., Hata, J., Woodward, M., Perkovic, V., Arima, H., Chow, C. K., Zoungas, S., Patel, A., Poulter, N. R., Mancia, G., et al. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.002832 · Cited by 68
Insights into the role of neuronal glucokinase
Backer, I. D., Hussain, S., Bloom, S. R., & Gardiner, J. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00034.2016 · Cited by 67
Chen, X.-J., Barywani, S. B., Hansson, P.-O., Östgärd Thunström, E., Rosengren, A., Ergatoudes, C., Mandalenakis, Z., Caidahl, K., & Fu, M. L. (2019) · Open Heart · doi:10.1136/openhrt-2018-000856 · Cited by 54
Nefs, G. M., Bazelmans, E., Donga, E., Tack, C. J., & de Galan, B. E. (2020) · Diabetic Medicine · doi:10.1111/dme.14211 · Cited by 30
Khaire, S. S., Gada, J. V., Utpat, K. V., Shah, N., Varthakavi, P. K., & Bhagwat, N. M. (2020) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-020-00098-0 · Cited by 20
BOWDEN, T. L., Letourneau, L. R., Kandasamy, B., Sanyoura, M., Tian, P., Harris, A. G., Bell, G. I., Philipson, L. H., Naylor, R. N., & Greeley, S. A. W. (2021) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2021.735548 · Cited by 20
Self-citationRen, Q., Zhang, P., Pang, W., Ma, Y., Gong, S., Ba, T., Liu, W., Zhang, F., Zhang, X., Zhang, R., et al. (2023) · Diabetes · doi:10.2337/db22-0566 · Cited by 14
Pamidi, S., Chapotot, F., Wroblewski, K., Whitmore, H., Polonsky, T., & Tasali, E. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.016871 · Cited by 10
Self-citationFranco, L. F., Szarf, G., Dotto, R. P., Dib, S. A., Moises, R. S., Giuffrida, F. M. A., & Reis, A. F. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108867 · Cited by 9
Schiabor Barrett, K. M., Telis, N., McEwen, L. M., Burrows, E. K., Khuder, B., Judge, D. P., Pawloski, P. A., Grzymski, J. J., Washington, N. L., Bolze, A., et al. (2024) · Communications Medicine · doi:10.1038/s43856-024-00663-z · Cited by 8 · cited 1×
“…studies have shown differences in cardiovascular risk for MODY, with GCK-MODY having a lower risk of coronary artery disease compared with type 2 diabetes (25) and a lower risk of diabetes-related complications overall, except for in individuals who could have superimposed type 2 diabetes (26).”
Steenkamp, D. W., Cheney, M. C., Ju, Z., Rodbard, D., & Wolpert, H. A. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad038 · Cited by 7 · cited 1×
“There are only a few prior reports on CGM profiles in GCK-MODY and TF-related MODY, which warrants future research (18,19).”
Objective and subjective sleep patterns in adults with maturity-onset diabetes of the young (MODY)
Arosemena, M., Salguero, M. V., Naylor, R. N., Wroblewski, K., Tasali, E., & Philipson, L. H. (2023) · Diabetes Care · doi:10.2337/dc22-1343 · Cited by 4
Self-citationObjective and Subjective Sleep Patterns in Adults with Maturity-Onset Diabetes of the Young (MODY)
Arosemena, M., Salguero, M. V., Naylor, R. N., et al. (2023) · doi:10.2337/figshare.21753662
Self-citationRen, Q., Zhang, P., Pang, W., et al. (2023) · doi:10.2337/figshare.22285438
Research works printed but not linked: 2
- Naylor RN , PhilipsonLH. Diagnosis and clinical management of monogenic diabetes. In Endotext.FeingoldKR, AnawaltB, BoyceA, ChrousosG, de HerderWW, DhatariyaK, , Eds. South Dartmouth, MA, MDText.com, Inc., 2000. Accessed 20 June 2022. Available from https://www.ncbi.nlm.nih.gov/books/NBK563964/
- Salguero MV , ArosemenaM, PollinT, GreeleySAW, NaylorRN, Letourneau-FreibergL, . Monogenic forms of diabetes. In Diabetes in America.LawrenceJM, CasagrandeSS, HermanWH, WexlerDJ, CefaluWT, Eds. Bethesda, MD, National Institute of Diabetes and Digestive and Kidney Diseases, 2023. Accessed 8 July 2024. Available from https://www.ncbi.nlm.nih.gov/books/NBK597414/
Cited by
Zhang, M., Li, C., Wang, X., Liu, R., Chen, Q., & Wu, C. (2026) · Future Science OA · doi:10.1080/20565623.2026.2636257
Wang, Z., Zhao, A., Ma, C., et al. (2026) · Medicine · doi:10.1097/md.0000000000049092
Metadata
- Authors
- Arosemena, M., Chopra, K., Salguero, M. V., Reyes, D., Naylor, R. N., Wroblewski, K., Tasali, E., & Philipson, L. H.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- University of Chicago (US)
- Advocate Children's Hospital (US)
- Corresponding author
- Arosemena, Marilyn
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2025-11-13
- Volume
- 75
- Issue
- 1
- Pages
- 215-222
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC12716610
- OpenAlex
- W4416179704
- Cited by
- 2
- References
- 26
- Citations by year
- 2026: 2
- FWCI
- 1.27
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion)
- Funders
- Doris Duke Charitable Foundation (20222028)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Keywords
- obstructive sleep apnea, maturity-onset diabetes of the young, resting heart rate, glycemic variability, HNF1A, HNF4α, HNF1B, cardiovascular risk, glycemic control, home sleep testing, continuous glucose monitoring, cardiovascular risk assessment, wearable activity trackers
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 2, Female, Heart Rate, Humans, Male, Middle Aged, Sleep Apnea, Obstructive, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.